Therapeutic Asset Ratings
290 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
VINDESINE
Adult T-cell Leukemia-Lymphoma
The First Affiliated Hospital of Soochow University
P2
B
(57)
Fludarabine
B-cell adult acute lymphocytic leukemia
The First Affiliated Hospital of Soochow University
P1/2
B
(56)
Tafasitamab
relapsed/refractory diffuse large B-cell lymphoma
The First Affiliated Hospital of Soochow University
P2
CCC
(55)
Azacitidine
B-cell acute lymphoblastic leukemia
The First Affiliated Hospital of Soochow University
P2
CCC
(54)
Flumatinib
mixed phenotype acute leukemia
The First Affiliated Hospital of Soochow University
P2
CCC
(54)
5-azacytidine
Refractory Acute Leukemia
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
5-azacytidine
Relapsed Adult AML
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
ag-120
IDH1 Gene Mutation
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
ag-120
Ivosidenib
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Azacytidine
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
Conditioning Therapy
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Anti-Thymoglobulin, Rabbit
SHR2554
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Avapritinib
KIT Mutation-Related Tumors
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
Azacytidine
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
Conditioning Therapy
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
Consolidation Therapy
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
High Risk
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
IDH1 Gene Mutation
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
Ivosidenib
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
Recruiting
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
SHR2554
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Azacitidine
Venentoclax
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Blinatumomab
Inotuzumab Ozogamicin
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Blinatumomab
Myeloproliferative Neoplasm
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Busulphan
Autologous Stem Cell Transplantation
The First Affiliated Hospital of Soochow University
P2
CCC
(53)
Showing 101 to 125 of 290 assets
Previous
Page 5 of 12
Next